Objective: To assess the effect of age on clinical, endocrine and sonographic features associated with polycystic ovary syndrome (PCOS) in normogonadotrophic anovulatory infertile women of reproductive years. Design: Cross-sectional study. Methods: Four hundred and seventy-two oligo-amenorrhoeic infertile patients, presenting with normal FSH and oestradiol concentrations, aged 17±42 years underwent a standardised initial evaluation including: cycle history, body mass index, waist-to-hip ratio and transvaginal ultrasound scanning of ovaries. Fasting blood samples were obtained for extensive endocrine evaluation. Cycle duration, serum levels of gonadotrophins, androgens, oestradiol, insulin, glucose, inhibin B as well as mean number of follicles, ovarian volume and ovarian stroma echogenicity were assessed. Results: Older women had signi®cantly lower LH and androgen and inhibin B serum levels. Similarly, older women presented with a reduced number of ovarian follicles. Age was inversely correlated with cycle duration r 20X112Y P 0X02Y LH r 20X154Y P 0X001Y testosterone r 20X194Y P 0X001Y androstenedione r 20X170Y P 0X001Y dehydroepiandrosterone r 20X157Y P 0X001Y insulin r 20X126Y P 0X02Y inhibin B r 20X118Y P 0X03 serum levels and mean follicle number r 20X100Y P 0X03X A positive correlation was observed between age and glucose to insulin ratio r 0X138Y P 0X009X Conclusions: Advanced age in normogonadotrophic anovulatory infertile women is associated with lower LH and androgen levels and with a decreased number of ovarian follicles. Although during reproductive years observed differences are relatively small, these age-related changes may affect the observed incidence of PCOS.
Introduction
Demographic and clinical studies show that various cycle characteristics change with age in normoovulatory women of reproductive age (1, 2) . Menstrual cycles become shorter, due to decreasing follicular phase length (3) . After the age of 35, follicle-stimulating hormone (FSH) levels begin to increase together with a subtle decrease in inhibin B without simultaneous changes in oestradiol (E 2 ) (4±6). Moreover, a steady gradual decline with age has been observed in serum androgens (7) . Finally, the number of antral follicles assessed during the early follicular phase has recently been shown to decrease with advanced age (8) .
The diagnosis of polycystic ovary syndrome (PCOS) in anovulatory infertile women is usually based on clinical characteristics in combination with hormonal and sonographic evaluation. Although hyperandrogenaemia seems to play a central role, no agreement has been reached so far concerning criteria required for diagnosis (9, 10) and the age of the patients is not taken into account. Preliminary observations suggest that a gradual normalisation of menstrual cycle abnormalities occurs in PCOS patients with increasing age (11, 12) . In contrast, other investigators (13) could not con®rm such changes. Moreover, some studies recorded a decline in serum androgen levels with age in hyperandrogenic PCOS patients as well as in controls (14, 15) . Hence, ignoring the patient's age may result in over-or under-diagnosis of the syndrome. Notwithstanding the extensive study of PCOS, little information is available concerning the potential effect of age especially on the extent of cycle abnormality, body weight and hyperandrogenaemia. The objective of the present study was to assess the effect of increasing age on clinical, endocrine and sonographic features associated with PCOS in a large cohort of normogonadotrophic oligo-amenorrhoeic infertile patients of reproductive years.
Materials and methods

Subjects
Four hundred and seventy-two infertile women, attending our fertility clinic between February 1993 and September 1999, presenting with oligomenorrhoea (interval between vaginal bleeding .35 days and #6 months) or amenorrhoea (bleeding interval .6 months) were enrolled in this cross-sectional study. The study protocol was approved by the human subject committee of the Erasmus University. Additional inclusion criteria were: (i) FSH levels within normal limits (1±10 IU/l), and (ii) spontaneous or progestogeninduced withdrawal bleeding (9, 16) . Exclusion criteria were: (i) serious illnesses such as kidney, liver, heart, vascular, thyroid diseases, or diabetes mellitus (fasting glucose .6 nmol/l), (ii) use of exogenous hormones, (iii) hyperprolactinaemia (PRL.15.5 mg/l), (iv) periovulatory E 2 levels (.400 pmol/l), or (v) luteal phase progesterone levels (.15 nmol/l).
Standardised clinical screening and transvaginal sonography (TVS) were performed and a fasting blood sample was obtained on a random day. Clinical screening included physical examination, menstrual and reproductive history, body mass index (BMI), waistto-hip ratio (WHR), surgery and previous medication. BMI was calculated as weight (kg)/height squared (m 2 ). WHR was de®ned as the minimum circumference at the waist divided by the maximum extension over the buttock, and was utilised as an index for different patterns of body fat distribution. The contribution of BMI and WHR on the effect of age on the studied parameters was evaluated because overweight is more common in older women.
Endocrine screening included serum measurements of FSH, luteinising hormone (LH), E 2 , progesterone, 17-hydroxyprogesterone (17-OHP), testosterone, androstenedione (AD), dehydroepiandrosterone (DHEAS), sex hormone binding globulin (SHBG), free androgen index FAI Testosterone Â 100aSHBGY insulin, glucose, inhibin B and cortisol. Fasting blood samples were taken by venepuncture between 0800 and 1000 h. Serum was obtained by centrifugation and frozen in aliquots at 220 8C, for subsequent analysis.
TVS screening included assessment of the ovarian stroma echogenicity (arbitrarily classi®ed from 1 to 3), ovarian volume (ml), and total number of antral follicles (both ovaries), as previously described (9, 17) . Mean follicle number and mean ovarian volume were calculated as the addition of left and right, divided by two and total stroma count was the stroma score addition of the left and the right ovary. For reasons of comparison PCOS was de®ned as elevated androgens (FAI.4.5) and polycystic ovaries (mean ovarian volume .10.8 ml) (NIH consensus meeting, NIEHS Durham, NC, USA, September 2000) (9).
Hormone assays
Serum LH and FSH levels were measured by immunoradiometric assay (Medgenix, Fleurus, Belgium), and E 2 , testosterone, AD, SHBG and DHEAS were determined using RIA kits (Diagnostic Products Corp., Los Angeles, CA, USA) as described previously (18) . Insulin was measured by two-site chemiluminescent enzymelabelled immunometric assay (Diagnostic Products Corp.). For inhibin B assays a dimeric immunoassay kit, solid phase sandwich ELISA (Serotec, Kidlington, Oxford, UK) was used (19) . Intra-and interassay coef®cients of variation were less than 5% and 15% for LH, less than 3% and 8% for FSH, less than 4% and 7% for E 2 , less than 6% and 7% for testosterone, less than 8% and 11% for AD, less than 7% and 8% for DHEAS, less than 6% and 8% for SHBG, less than 16% and 17% for progesterone, less than 6% and 10% for insulin, less than 1% and 2% for glucose, less than 8% and 14% for inhibin B and less than 9% and 10% for cortisol respectively
Statistical analysis
All data were analysed for normality of distribution. Pearson's correlation test was used when data were distributed normally. If not, Spearman's rank correlation test was performed. Covariance analysis was used to describe the linear relationship between variables while controlling for the effects of one or more confounding variables. Student's t-test or Mann± Whitney U test were used to compare the means between subsets of data. The two-tailed P value of ,0.05 was used to de®ne statistical signi®cance.
Results
A total of 472 patients ranging between 17 and 42 years of age (28X5^4X5 years) were evaluated in this study. Clinical, endocrine and ultrasound characteristics of these 472 women are presented in Table 1 . Women were also grouped by age: 17±29 and $30±42 years. Differences for LH, LH/FSH ratio, testosterone, AD, DHEAS, mean number of follicles and the percentage of PCOS subjects were found to be statistically signi®cant (Table 1) .
In the study population, age was inversely correlated with cycle duration, LH, testosterone, AD, DHEAS, FAI, SHBG, insulin, inhibin B levels and mean follicle number (Table 2) . Bivariate correlations between age and biologically pertinent parameters such as cycle duration, LH, FSH, androgens and inhibin B are depicted in Figs 1±3 .
No signi®cant correlation between age and E 2 levels was found; neither between age and BMI, WHR, mean ovarian volume, nor total stroma score ( Table 2) . No changes in correlations of all the aforementioned parameters with age were observed when patients were grouped and analysed according to the cycle duration (oligomenorrhoeic vs amenorrhoeic women; data not shown).
Covariance analysis to evaluate the relative contribution of BMI and WHR on the effect of age on the studied parameters revealed no differences in the strength of correlation among these variables (data not shown).
Discussion
Although abnormalities observed in PCOS have been studied extensively, little information is available concerning possible changes in clinical, endocrine and sonographic features associated with increasing age. In the current cross-sectional study in a large cohort of normogonadotrophic anovulatory infertile women, weak but statistically signi®cant inverse correlations were observed between age and cycle duration, LH, androgens, SHBG, insulin, inhibin B and mean number of ovarian follicles. In addition, LH, testosterone, AD, and DHEAS concentrations were decreased in women over 30 years compared with younger women. Moreover, the mean number of follicles was signi®cantly decreased and polycystic ovaries were less frequently encountered in older women. The slight decline in cycle duration with increasing age that we found may be related to the simultaneous fall in androgens. It is known that both normal weight and obese oligomenorrhoeic hirsute patients exhibit higher testosterone and FAI levels compared with normo-ovulatory hirsute women (20, 21) . Thus, it seems that androgen levels are correlated more with menstrual pattern than with patient's weight. We could not con®rm a positive correlation between age and BMI, as described previously (22) . This may be explained by the inclusion of anovulatory rather than normally cycling women and by the relatively young age of the current study population.
Data from the present cross-sectional study do not provide strong evidence that the incidence of cycle abnormalities in PCOS women is related to their age. In contrast, other longitudinal studies (11, 12) suggested that cycle abnormalities tend to normalise with age. This discrepancy may again be due to differences in age of the patients studied, but also differences in study design, and criteria used to diagnose PCOS. Moreover, women with cycle abnormalities at advanced age are more likely to use steroid contraceptives and therefore their spontaneous cycle cannot be assessed in longitudinal follow-up studies. Indeed, the number of dropouts from reported follow-up studies is very high. However, it should be emphasised that the current cross-sectional study does not rule out cycle changes over time.
In normal women of reproductive age, the negative relationship of age with serum androgens has been established by previous investigators (6, 23) . In addition, it has been shown that in hirsute hyperandrogenic women, the negative association between testosterone, AD, DHEAS levels and age is preserved (15) . Our observations con®rm these previous ®ndings and suggest that the age of the patients should be taken into consideration when evaluating the hormonal pro®le of normogonadotrophic anovulatory infertile patients. The weak correlations found do not permit us to interpret these data as disease amelioration, but rather a physiological decline also observed in healthy women. It has been suggested that both adrenal and ovarian contributions to serum androgens decline with age (24) .
In the current study, fasting serum insulin concentrations were not consistently increased and average levels were within the normal range as observed in other studies (25, 26) . Hyperinsulinaemia is most prominent in obese PCOS patients (27) and the present study included both lean and obese women. A weak positive correlation between age and fasting glucose to insulin ratio was observed, suggesting that a slight amelioration of insulin resistance may occur with age. This is in accordance with a gradual decline in androgen levels with age since insulin may be directly involved in androgen production at the ovarian level (28) .
LH concentrations were reported to remain unchanged in women with regular menstrual cycles, even above 45 years of age (29) . Other studies reported a rise in LH, almost simultaneous with FSH (30) . The ®nding of a weak inverse relationship between age and LH in the current study in anovulatory women is unexpected and surprising. A statistically signi®cant decrease in LH levels was also observed when young women were compared with those above 30 years of age. In a recent 10-year follow-up study (31) gonadotrophin levels were signi®cantly reduced in PCOS Figure 3 Bivariate correlations between parameters associated with normal ovarian ageing ± cycle duration, mean follicle number and serum inhibin B concentrations ± with age in 472 normogonadotrophic oligo-amenorrhoeic infertile patients.
The effect of age on PCOS-associated features patients using oestrogen±progestogen compounds, but showed no decline in non-users. Another study (13) was unable to ®nd differences in gonadotrophin levels comparing adolescent and adult PCOS patients. Recent work from our group suggest that initial LH concentrations do not predict ovarian responsiveness to ovulation induction, indirectly opposing the concept that elevated LH levels are involved in ovarian dysfunction in these patients (18) . Moreover, a single assessment of LH levels is of limited signi®cance due to the timing of blood sampling, immunoassays used and the pulsatile nature of LH secretion (32) . For all the aforementioned reasons, the pathophysiological relevance of the observed slight decline in LH with increasing age remains uncertain.
It is well established that in normal women the depletion of ovarian follicles continues during the reproductive years until the supply of resting primordial follicles is exhausted (1) . Indeed, in normo-ovulatory women the number of antral follicles assessed by ultrasound decreases with age (8, 33) . In PCOS only advanced stages of follicle maturation are arrested, resulting in an increased number of small antral follicles (34) . No information is available concerning the extent of follicle depletion or menopausal age in PCOS women. In the current study in anovulatory women we found for the ®rst time a reduction in follicle number with increasing age, in line with normoovulatory women. Combining these observations concerning LH, androgens and mean follicle numbers and de®ning PCOS as polycystic ovaries and elevated LH and androgen levels, the incidence of PCOS in normoovulatory infertile women may decrease over time.
The pattern of FSH and inhibin B secretion in normal women of reproductive age has previously been characterised (1, 4, 30, 35) . FSH begins to rise at the age of 35 with a marked increase beyond 40 years. Inhibin B demonstrates a slight drop at the age of 35 and declines thereafter (29, 35) . Moreover, inhibin B serum levels are normal in normogonadotrophic anovulatory women as well as in PCOS patients (36) . In the current study, anovulatory women with elevated or reduced FSH were excluded since these groups represent different aetiological entities such as premature menopause. However, the normal range for FSH is wide (1±10 IU/l) and age-related changes may be established. From our data (showing no correlation of age with FSH and a weak inverse correlation with inhibin B) we can conclude that inhibin B secretion in normogonadotrophic anovulatory women follows the same pattern as in healthy women. A direct inverse correlation between inhibin B and FSH could not be con®rmed.
In conclusion, the combined data of the current cross-sectional study do indicate appreciable changes in clinical, endocrine and ovarian characteristics associated with PCOS with increasing age in WHO class II anovulatory patients of reproductive age. It seems that observed minor changes follow the same pattern as in normo-ovulatory women of similar age. These changes may affect the observed incidence of PCOS. A longitudinal follow-up study should con®rm these observations and should further establish the precise timing and magnitude of observed alterations.
